Atogepant for the prevention of episodic migraine in adults

OBJECTIVE: Atogepant is a newly approved medication for the prevention of migraine. This review aims to discuss the efficacy, safety, cost, and place in therapy of atogepant. METHODS: The authors performed a systematic search for sources, including articles, abstracts, and poster presentations. Quer...

Descripción completa

Detalles Bibliográficos
Autores principales: Switzer, Maranda Paige, Robinson, Joseph Edward, Joyner, Kayla Rena, Morgan, Kelsey Woods
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549103/
https://www.ncbi.nlm.nih.gov/pubmed/36226229
http://dx.doi.org/10.1177/20503121221128688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549103/
https://www.ncbi.nlm.nih.gov/pubmed/36226229
http://dx.doi.org/10.1177/20503121221128688

Ejemplares similares